Ray of hope
Paluther, an anti-malarial drug developed by Chinese scientists in 1973, promises new hope to the millions suffering from the killer disease. On trial for the past 3 years in Tanzania and Kenya, the drug is expected to replace chloroquine and other anti-malarials in use in the 2 countries.
Shrikant Bhatt, who chairs the department of medicine in the University of Nairobi, says preliminary results show that Paluther is more effective than other anti-malarials. The growing resistance of certain malarial parasites to chloroquine has been disconcerting scientists across the world; Paluther's efficacy in building resistance to malaria and fighting malarial parasites as well will reassure them.
If introduced in the market, Paluther will join the SPF66, another anti-malarial vaccine developed by Columbian scientist Manuel Patarroyo, which is undergoing tests in Tanzania and Gambia.(IPS)
Related Content
- State of world population 2024: interwoven lives, threads of hope- ending inequalities in sexual and reproductive health and rights
- Integrating co-benefits into Nationally Determined Contributions, climate policies and air pollution policies in Asia
- Sahel human development report 2023: sustainable energy for economic and climate security in the Sahel
- Senegal as an LNG exporter? stranded asset risks in the transition
- Powering India’s future: towards a people-positive energy transition
- Demystifying carbon emission trading system through simulation workshops in India